Literature DB >> 21074428

The discovery and structure-activity relationships of indole-based inhibitors of glutamate carboxypeptidase II.

Brian Grella1, Jessica Adams, James F Berry, Greg Delahanty, Dana V Ferraris, Pavel Majer, Chiyou Ni, Krupa Shukla, Scott A Shuler, Barbara S Slusher, Marigo Stathis, Takashi Tsukamoto.   

Abstract

A series of N-substituted 3-(2-mercaptoethyl)-1H-indole-2-carboxylic acids were synthesized as inhibitors of glutamate carboxypeptidase II (GCPII). Those containing carboxybenzyl or carboxyphenyl groups at the N-position exhibited potent inhibitory activity against GCPII. These indole-based compounds represent the first example of achiral GCPII inhibitors and demonstrate greater tolerance of the GCPII active site for ligands with significant structural difference from the endogenous substrate, N-acetyl-aspartylglutamate.
Copyright © 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21074428     DOI: 10.1016/j.bmcl.2010.10.109

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

Review 1.  Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer.

Authors:  C Bařinka; C Rojas; B Slusher; M Pomper
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

2.  δ-Thiolactones as prodrugs of thiol-based glutamate carboxypeptidase II (GCPII) inhibitors.

Authors:  Dana V Ferraris; Pavel Majer; Chiyou Ni; C Ethan Slusher; Rana Rais; Ying Wu; Krystyna M Wozniak; Jesse Alt; Camilo Rojas; Barbara S Slusher; Takashi Tsukamoto
Journal:  J Med Chem       Date:  2013-12-27       Impact factor: 7.446

3.  Chiral Iodotriptycenes: Synthesis and Catalytic Applications.

Authors:  Nasim Khan; Katsunori Itaya; Thomas Wirth
Journal:  ChemistryOpen       Date:  2022-07       Impact factor: 2.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.